loadpatents
name:-0.010399103164673
name:-0.0095558166503906
name:-0.0070409774780273
Watt; David S Patent Filings

Watt; David S

Patent Applications and Registrations

Patent applications and USPTO patent grants for Watt; David S.The latest application filed is for "n-aryl benzenesulfonamides as protonophores for the treatment of cancers, metabolic diseases and traumatic brain injury".

Company Profile
6.8.10
  • Watt; David S - Lexington KY
  • Watt; David S. - Lexington KY
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
N-Aryl Benzenesulfonamides as Protonophores for the Treatment of Cancers, Metabolic Diseases and Traumatic Brain Injury
App 20220117920 - Watt; David S ;   et al.
2022-04-21
Drugs For Grp78 Cell Surface Translocation And Par-4 Secretion
App 20210252032 - Rangnekar; Vivek M. ;   et al.
2021-08-19
Semisynthetic Aurones And Methods Of Use Thereof
App 20200354348 - Blackburn; Jessica S. ;   et al.
2020-11-12
Antifungal Compounds And Methods Of Forming The Same
App 20200024224 - Garneau-Tsodikova; Sylvie ;   et al.
2020-01-23
Phenylethynyl-substituted benzenes and heterocycles for the treatment of cancer
Grant 10,449,186 - Watt , et al. Oc
2019-10-22
Cytisine-linked isoflavonoid antineoplastic agents for the treatment of cancer
Grant 10,188,743 - Liu , et al. Ja
2019-01-29
Bishydrazone-based antifungal agents
Grant 10,173,968 - Garneau-Tsodikova , et al. J
2019-01-08
Phenylethynyl-substituted Benzenes And Heterocycles For The Treatment Of Cancer
App 20180369222 - WATT; David S. ;   et al.
2018-12-27
Cytisine-linked Isoflavonoid Antineoplastic Agents For The Treatment Of Cancer
App 20180344862 - LIU; Chunming ;   et al.
2018-12-06
Arylquinoline and analog compounds and use thereof to treat cancer
Grant 9,873,670 - Watt , et al. January 23, 2
2018-01-23
Bishydrazone-based Antifungal Agents
App 20180009741 - Garneau-Tsodikova; Sylvie ;   et al.
2018-01-11
3-aryl-4H-chromene-4-ones as antineoplastic agents for the treatment of cancer
Grant 9,718,799 - Bondarenko , et al. August 1, 2
2017-08-01
Arylquinoline, Arylquinolone And Arylthioquinolone Derivatives And Use Thereof To Treat Cancer
App 20160332971 - WATT; David S. ;   et al.
2016-11-17
3-aryl-4h-chromene-4-ones As Antineoplastic Agents For The Treatment Of Cancer
App 20160332981 - BONDARENKO; Svitlana P. ;   et al.
2016-11-17
Method and system for producing triterpenes
Grant 9,487,762 - Chappell , et al. November 8, 2
2016-11-08
Arylquinoline And Analog Compounds And Use Thereof To Treat Cancer
App 20160280652 - WATT; David S. ;   et al.
2016-09-29
Polypeptides, nucleic acid molecules, and methods for synthesis of triterpenes
Grant 8,822,187 - Chappell , et al. September 2, 2
2014-09-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed